Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Important Indicators for Predicting in-Hospital Death in Elderly AMI Patients

References

• Pedersen F, Butrymovich V, Kelbæk H, et al. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol. 2014;64(20):2101–2108.
   PubMed Web of Science ®Google Scholar
• Fokkema ML, James SK, Albertsson P, et al. Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). J Am Coll Cardiol. 2013;61(12):1222–1230.
   PubMed Web of Science ®Google Scholar
• Kristensen SD, Laut KG, Fajadet J, et al. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. Eur Heart J. 2014;35(29):1957–1970.
   PubMed Web of Science ®Google Scholar
• Pasterkamp G, den Ruijter HM, Libby P. Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease. Nat Rev Cardiol. 2017;14(1):21–29.
   PubMed Web of Science ®Google Scholar
• Stone GW, Mintz GS, Virmani R. Vulnerable Plaques, Vulnerable Patients, and Intravascular Imaging. J Am Coll Cardiol. 2018;72(17):2022–2026.
   PubMed Web of Science ®Google Scholar
• Arbab-Zadeh A, Fuster V. The myth of the “vulnerable plaque”: transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol. 2015;65(8):846–855.
   PubMed Web of Science ®Google Scholar
• Ginsberg HN, Packard CJ, Chapman MJ, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42(47):4791–4806.
   PubMed Web of Science ®Google Scholar
• Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and Myocardial Infarction. N Engl J Med. 2019;380(2):171–176.
   PubMed Web of Science ®Google Scholar
• Webb RJ, Mazidi M, Lip GYH, Kengne AP, Banach M, Davies IG. The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B. Nutr Metab Cardiovasc Dis. 2022;32(3):605–615.
   PubMed Web of Science ®Google Scholar
• Mikolajczyk TP, Szczepaniak P, Vidler F, Maffia P, Graham GJ, Guzik TJ. Role of inflammatory chemokines in hypertension. Pharmacol Ther. 2021;223:107799.
   PubMed Web of Science ®Google Scholar
• Harrison DG, Marvar PJ, Titze JM. Vascular inflammatory cells in hypertension. Front Physiol. 2012;3:128.
   PubMed Web of Science ®Google Scholar
• Sheng J, Liu N, He F, Cheng C, Shen S, Sun Y. Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome. Clinics. 2021;76:e2580.
   PubMed Web of Science ®Google Scholar
• Kounis NG, Koniari I, Plotas P, et al. Inflammation, Thrombosis, and Platelet-to-Lymphocyte Ratio in Acute Coronary Syndromes. Angiology. 2021;72(1):6–8.
   PubMed Web of Science ®Google Scholar
• Li Q, Ma X, Shao Q, et al. Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients. Front Cardiovasc Med. 2022;9:811790.
   PubMed Web of Science ®Google Scholar
• Ugur M, Gul M, Bozbay M, et al. The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention. Blood Coagulation Fibrinolysis. 2014;25(8):806–811.
   PubMed Web of Science ®Google Scholar
• Azab B, Shah N, Akerman M, McGinn JT. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012;34(3):326–334.
   PubMed Web of Science ®Google Scholar
• Kurtul A, Yarlioglues M, Murat SN, et al. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Am J Cardiol. 2014;114(3):342–347.
   PubMed Web of Science ®Google Scholar
• Kaya A, Kurt M, Tanboğa IH. Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention. Angiology. 2014;65(1):59.
   PubMedGoogle Scholar
• Velibey Y, Oz A, Tanik O, et al. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology. 2017;68(5):419–427.
   PubMed Web of Science ®Google Scholar
• Ji Z, Liu G, Guo J, et al. The Neutrophil-to-Lymphocyte Ratio Is an Important Indicator Predicting In-Hospital Death in AMI Patients. Front Cardiovasc Med. 2021;8:706852.
   PubMed Web of Science ®Google Scholar
• Li XT, Fang H, Li D, et al. Association of platelet to lymphocyte ratio with in-hospital major adverse cardiovascular events and the severity of coronary artery disease assessed by the Gensini score in patients with acute myocardial infarction. Chin Med J. 2020;133(4):415–423.
   PubMed Web of Science ®Google Scholar
• Xia TL, Huang FY, Li YM, et al. The impact of age on the implementation of evidence-based medications in patients with coronary artery disease and its prognostic significance: a retrospective cohort study. BMC Public Health. 2018;18(1):150.
   PubMedGoogle Scholar
• Hayıroğlu M, Çınar T, Çinier G, et al. Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction. Pacing Clin Electrophysiol. 2022;45(2):188–195.
   PubMed Web of Science ®Google Scholar
• Shi S, Kong S, Ni W, et al. Association of the Systemic Immune-Inflammation Index with Outcomes in Acute Coronary Syndrome Patients with Chronic Kidney Disease. J Inflamm Res. 2023;16:1343–1356.
   PubMed Web of Science ®Google Scholar
• Alexander KP, Newby LK, Cannon CP, et al. Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115(19):2549–2569.
   PubMed Web of Science ®Google Scholar
• Hayıroğlu M, Keskin M, Uzun AO, et al. Predictors of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Complicated With Cardiogenic Shock. Heart Lung Circ. 2019;28(2):237–244.
   PubMed Web of Science ®Google Scholar
• Çınar T, Şaylık F, Akbulut T, et al. Evaluation of Intermountain Risk Score for Short- and Long-Term Mortality in ST Elevation Myocardial Infarction Patients. Angiology. 2023;74(4):357–364.
   PubMed Web of Science ®Google Scholar
• Mert Ilker H, Faysal S, Ahmet Çağdaş Y, Murat S, Tufan Ç. Prognostic value of Intermountain Risk Score for short- and long-term mortality in patients with cardiogenic shock. Coron Artery Dis. 2023;34(2):154–159.
   PubMed Web of Science ®Google Scholar
• Templeton AJ, Ace O, McNamara MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23(7):1204–1212.
   PubMed Web of Science ®Google Scholar
• Budzianowski J, Pieszko K, Burchardt P, Rzeźniczak J, Hiczkiewicz J. The Role of Hematological Indices in Patients with Acute Coronary Syndrome. Dis Markers. 2017;2017:3041565.
   PubMed Web of Science ®Google Scholar
• Döring Y, Soehnlein O, Weber C. Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis. Circ Res. 2017;120(4):736–743.
   PubMed Web of Science ®Google Scholar
• Darbousset R, Thomas GM, Mezouar S, et al. Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation. Blood. 2012;120(10):2133–2143.
   PubMed Web of Science ®Google Scholar
• Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation. 2010;122(18):1837–1845.
   PubMed Web of Science ®Google Scholar
• Paul GK, Sen B, Bari MA, et al. Correlation of platelet count and acute ST-elevation in myocardial infarction. Mymensingh Med J. 2010;19(3):469–473.
   PubMedGoogle Scholar
• Lievens D, von Hundelshausen P. Platelets in atherosclerosis. Thromb Haemost. 2011;106(5):827–838.
   PubMed Web of Science ®Google Scholar
• Ammirati E, Moroni F, Magnoni M, Camici PG. The role of T and B cells in human atherosclerosis and atherothrombosis. Clin Exp Immunol. 2015;179(2):173–187.
   PubMed Web of Science ®Google Scholar
• Núñez J, Miñana G, Bodí V, et al. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18(21):3226–3233.
   PubMed Web of Science ®Google Scholar
• Bergquist J, Tarkowski A, Ewing A, Ekman R. Catecholaminergic suppression of immunocompetent cells. Immunol Today. 1998;19(12):562–567.
   PubMedGoogle Scholar
• Mooren FC, Blöming D, Lechtermann A, Lerch MM, Völker K. Lymphocyte apoptosis after exhaustive and moderate exercise. J Appl Physiol. 2002;93(1):147–153.
   PubMed Web of Science ®Google Scholar
• Li L, Ma Y, Geng XB, et al. Platelet-to-lymphocyte ratio relates to poor prognosis in elderly patients with acute myocardial infarction. Aging Clin Exp Res. 2021;33(3):619–624.
   PubMed Web of Science ®Google Scholar
• Chen B, Yuan L, Chen X, et al. Correlations and Prognostic Roles of the Nutritional Status and Neutrophil-to-lymphocyte Ratio in Elderly Patients with Acute Myocardial Infarction Undergoing Primary Coronary Intervention. Int Heart J. 2020;61(6):1114–1120.
   PubMed Web of Science ®Google Scholar
• Giakoumidakis K, Fotos NV, Patelarou A, et al. Perioperative neutrophil to lymphocyte ratio as a predictor of poor cardiac surgery patient outcomes. Pragmatic Obser Res. 2017;8:9–14.
   PubMed Web of Science ®Google Scholar
• Ozcan Cetin EH, Cetin MS, Aras D, et al. Platelet to Lymphocyte Ratio as a Prognostic Marker of In-Hospital and Long-Term Major Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction. Angiology. 2016;67(4):336–345.
   PubMed Web of Science ®Google Scholar
• Gheeraert PJ, De Buyzere ML, Taeymans YM, et al. Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis. Eur Heart J. 2006;27(21):2499–2510.
   PubMed Web of Science ®Google Scholar
• Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569–2619.
   PubMed Web of Science ®Google Scholar
• Pitt B, White H, Nicolau J, et al. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol. 2005;46(3):425–431.
   PubMed Web of Science ®Google Scholar
• Marcolino MS, Maia LM, Oliveira JAQ, et al. Impact of telemedicine interventions on mortality in patients with acute myocardial infarction: a systematic review and meta-analysis. Heart. 2019;105(19):1479–1486.
   PubMed Web of Science ®Google Scholar